Ribocare (Riboflavin)

Riboflavin (vitamin B2), marketed as Ribocare, is converted in the body to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), two coenzymes essential for cellular energy production. These coenzymes drive oxidative phosphorylation and macronutrient metabolism by acting as electron carriers in mitochondrial redox reactions.

Origin & History

Riboflavin (Ribocare) is a water-soluble vitamin B2 with the chemical formula C₁₇H₂₀N₄O₆, occurring naturally in foods such as whey and egg white. It is industrially produced synthetically or extracted and purified into a yellow-orange crystalline powder, though specific extraction methods are not detailed.

Historical & Cultural Context

No historical context or traditional medicine systems (e.g., Ayurveda, TCM) are mentioned for Ribocare (Riboflavin) in the search results. The research provides no information on traditional uses.

Health Benefits

• Essential for energy metabolism as a precursor to FMN and FAD coenzymes (evidence quality not specified in research)
• Supports carbohydrate, fat, and protein metabolism through redox reactions (evidence quality not specified)
• Facilitates electron transport in oxidative phosphorylation (evidence quality not specified)
• Exhibits redox-active properties for cellular functions (evidence quality not specified)
• Light-sensitive compound with UV absorption properties at 260-370 nm (evidence quality not specified)

How It Works

Riboflavin is phosphorylated by riboflavin kinase to form FMN, which is subsequently adenylated by FAD synthetase to produce FAD. Both coenzymes serve as prosthetic groups for flavoproteins involved in the mitochondrial electron transport chain, including NADH dehydrogenase (Complex I) and succinate dehydrogenase (Complex II), facilitating electron transfer to ubiquinone. FAD also participates in the beta-oxidation of fatty acids and amino acid catabolism via enzymes such as acyl-CoA dehydrogenase, directly linking riboflavin status to the metabolism of all three macronutrient classes.

Scientific Research

The research dossier lacks specific details on human clinical trials, RCTs, or meta-analyses for Ribocare (Riboflavin). No PubMed PMIDs, study designs, sample sizes, or clinical outcomes are provided in the available sources.

Clinical Summary

Randomized controlled trials have investigated high-dose riboflavin (400 mg/day) for migraine prophylaxis, with a landmark placebo-controlled trial of 55 patients showing a 50% reduction in attack frequency after 3 months, though effect sizes in subsequent meta-analyses have been more modest. Observational studies suggest that dietary riboflavin deficiency correlates with impaired iron absorption and anemia, though interventional evidence in replete populations is limited. Evidence for riboflavin's role in cataracts prevention comes primarily from epidemiological cohort data rather than RCTs, making causal conclusions premature. Overall, the strongest clinical evidence supports its use in migraine prevention at pharmacological doses, while metabolic and antioxidant benefits are well-mechanistically supported but less rigorously quantified in human trials.

Nutritional Profile

Riboflavin (Vitamin B2, C17H20N4O6, MW 376.36 g/mol). Active forms: Flavin mononucleotide (FMN) and Flavin adenine dinucleotide (FAD), which serve as essential coenzymes in >80 flavoprotein-catalyzed reactions. Typical supplement doses range from 1.3–400 mg per unit, with the RDA set at 1.1 mg/day (women) and 1.3 mg/day (men). Bioavailability: Absorption occurs primarily in the proximal small intestine via a saturable, carrier-mediated transport system (RFVT1/SLC52A1 and RFVT2/SLC52A2 transporters); maximal single-dose absorption is approximately 25–27 mg, meaning doses above ~27 mg yield diminishing absorption efficiency. Food-bound riboflavin (as FMN/FAD) requires enzymatic hydrolysis by intestinal phosphatases before absorption. Free riboflavin bioavailability from supplements on an empty stomach is estimated at ~60–65%; absorption is enhanced when taken with food (particularly fat-containing meals) due to delayed gastric emptying. Riboflavin is water-soluble with limited tissue storage; excess is rapidly excreted renally (producing characteristic yellow-green fluorescent urine). Plasma half-life is approximately 66–84 minutes. No significant macronutrient content (negligible calories, no fat, carbohydrate, protein, or fiber). Contains no minerals. The isoalloxazine ring system is the bioactive chromophore responsible for redox activity, cycling between oxidized (quinone), semiquinone, and fully reduced (hydroquinone) states, enabling 1- and 2-electron transfer reactions. Riboflavin is photosensitive (degraded by UV/visible light, particularly at 445 nm), and stability is pH-dependent (most stable at pH 3.5–4.0). Enteric-coated or sustained-release formulations may improve total absorption by reducing the rate of intestinal transit and avoiding saturation of transport mechanisms.

Preparation & Dosage

No clinically studied dosage ranges for Ribocare (Riboflavin) in forms like extract, powder, or standardized versions are specified in the research results. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other B-complex vitamins, Magnesium, Iron, Zinc, Coenzyme Q10

Safety & Interactions

Riboflavin is considered very safe; excess intake is rapidly excreted renally, causing harmless bright yellow discoloration of urine (flavinuria) without toxicity, and no established tolerable upper intake level has been set by the Institute of Medicine. High-dose riboflavin (400 mg/day) is generally well-tolerated in clinical trials with no serious adverse events reported. It may reduce the efficacy of tetracycline antibiotics by impairing absorption when taken concomitantly, and tricyclic antidepressants such as imipramine can inhibit riboflavin absorption in the gastrointestinal tract. Riboflavin is considered safe during pregnancy and is classified as Category A; the RDA increases to 1.4 mg/day during pregnancy to support fetal development.